- Home
- APT vs ABOS Comparison
APT vs ABOS Comparison
Compare APT & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APT
- ABOS
- Stock Information
- Founded
- APT 1983
- ABOS 1996
- Country
- APT Canada
- ABOS United States
- Employees
- APT N/A
- ABOS N/A
- Industry
- APT
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- APT
- ABOS Health Care
- Exchange
- APT Nasdaq
- ABOS Nasdaq
- Market Cap
- APT 61.6M
- ABOS 66.6M
- IPO Year
- APT 1995
- ABOS 2021
- Fundamental
- Price
- APT $4.50
- ABOS $0.98
- Analyst Decision
- APT
- ABOS Strong Buy
- Analyst Count
- APT 0
- ABOS 3
- Target Price
- APT N/A
- ABOS $7.33
- AVG Volume (30 Days)
- APT 11.0K
- ABOS 215.0K
- Earning Date
- APT 05-08-2025
- ABOS 05-13-2025
- Dividend Yield
- APT N/A
- ABOS N/A
- EPS Growth
- APT 2.28
- ABOS N/A
- EPS
- APT 0.36
- ABOS N/A
- Revenue
- APT $58,180,000.00
- ABOS N/A
- Revenue This Year
- APT N/A
- ABOS N/A
- Revenue Next Year
- APT N/A
- ABOS N/A
- P/E Ratio
- APT $12.70
- ABOS N/A
- Revenue Growth
- APT N/A
- ABOS N/A
- 52 Week Low
- APT $4.06
- ABOS $0.86
- 52 Week High
- APT $6.44
- ABOS $3.92
- Technical
- Relative Strength Index (RSI)
- APT 48.53
- ABOS 43.50
- Support Level
- APT $4.45
- ABOS $0.96
- Resistance Level
- APT $4.72
- ABOS $1.13
- Average True Range (ATR)
- APT 0.14
- ABOS 0.08
- MACD
- APT 0.04
- ABOS 0.00
- Stochastic Oscillator
- APT 47.62
- ABOS 10.71
About APT Alpha Pro Tech Ltd.
Alpha Pro Tech Ltd is involved in the business of developing, manufacturing, and marketing of disposable protective apparel, building supply, and infection control products principally in the United States. It operates its business through segment which includes Building Supply and Disposable Protective Apparel. It mainly offers a line of construction supply weatherization products, namely house wrap and synthetic roof underlayment as well as other woven material, different styles of disposable products like shoe covers, bouffant caps, gowns, coveralls, lab coats, frocks and other miscellaneous products. It also provides face masks and eye shields. It generates most of its revenues from the sale of products across the United States.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.